Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    NCT02046070
Show Display Options
Rank Status Study
1 Active, not recruiting Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Cyclophosphamide;   Drug: Ixazomib (MLN9708);   Drug: Dexamethasone

Study has passed its completion date and status has not been verified in more than two years.